Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Welch

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Stroke|May 23, 2009
Relative and cumulative effects of lipid and blood pressure control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels trialPierre Amarenco, Larry B Goldstein, Michael Messig, et al.
The New England Journal of Medicine|August 11, 2006
High-dose atorvastatin after stroke or transient ischemic attackPierre Amarenco, Julien Bogousslavsky, Alfred Callahan, et al.
Atherosclerosis|October 31, 2008
Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trialPierre Amarenco, Larry B Goldstein, Alfred Callahan, et al.
JAMA|March 29, 2012
Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysisS Matthijs Boekholdt, Benoit J Arsenault, Samia Mora, et al.
Circulation|August 23, 2013
Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysisS Matthijs Boekholdt, Benoit J Arsenault, G Kees Hovingh, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Stroke|May 23, 2009
Relative and cumulative effects of lipid and blood pressure control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels trialPierre Amarenco, Larry B Goldstein, Michael Messig, et al.
The New England Journal of Medicine|August 11, 2006
High-dose atorvastatin after stroke or transient ischemic attackPierre Amarenco, Julien Bogousslavsky, Alfred Callahan, et al.
Atherosclerosis|October 31, 2008
Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trialPierre Amarenco, Larry B Goldstein, Alfred Callahan, et al.
JAMA|March 29, 2012
Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysisS Matthijs Boekholdt, Benoit J Arsenault, Samia Mora, et al.
Circulation|August 23, 2013
Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysisS Matthijs Boekholdt, Benoit J Arsenault, G Kees Hovingh, et al.
Pageof 5